Evidence map›Paper›PMID 29633150›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2018

Genetics of personalized medicine: cancer and rare diseases.

Inês Teles Siefers Alves, Manuel Condinho, Sónia Custódio, Bruna F Pereira, Rafael Fernandes, Vânia Gonçalves, Paulo J da Costa, Rafaela Lacerda, Ana Rita Marques, Patrícia Martins-Dias and 10 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Nonsense suppression therapies in human genetic diseases.Cellular and molecular life sciences : CMLS · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Inês Teles Siefers AlvesDepartment of Cell Biology and Biochemistry, Springer Science + Business Media B.V, Van Godewijckstraat 30, 3311, GX, Dordrecht, The Netherlands. ines.alves@springernature.com.
Manuel CondinhoDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Sónia CustódioMedical Genetics Service, Pediatric Department, Hospital Santa Maria, Lisbon, Portugal.
Bruna F PereiraDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Rafael FernandesDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Vânia GonçalvesDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Paulo J da CostaDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Rafaela LacerdaDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Ana Rita MarquesDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Patrícia Martins-DiasDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Gonçalo R NogueiraDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Ana Rita NevesDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
Patrícia PinhoGenetics Laboratory, Hospital Center of Trás-os-Montes and Alto Douro, Vila Real, Portugal.
Raquel RodriguesMedical Genetics Service, Pediatric Department, Hospital Santa Maria, Lisbon, Portugal.
Eva RoloMedical Genetics Service, Pediatric Department, Hospital Santa Maria, Lisbon, Portugal.
Joana SilvaDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.
André TravessaMedical Genetics Service, Pediatric Department, Hospital Santa Maria, Lisbon, Portugal.
Rosário Pinto LeiteGenetics Laboratory, Hospital Center of Trás-os-Montes and Alto Douro, Vila Real, Portugal.
Ana SousaMedical Genetics Service, Pediatric Department, Hospital Santa Maria, Lisbon, Portugal.
Luísa RomãoDepartment of Human Genetics, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 21st annual meeting of the Portuguese Society of Human Genetics (SPGH), organized by Luísa Romão, Ana Sousa and Rosário Pinto Leite, was held in Caparica, Portugal, from the 16th to the 18th of November 2017. Having entered an era in which personalized medicine is emerging as a paradigm for disease diagnosis, treatment and prevention, the program of this meeting intended to include lectures by leading national and international scientists presenting exceptional findings on the genetics of personalized medicine. Various topics were discussed, including cancer genetics, transcriptome dynamics and novel therapeutics for cancers and rare disorders that are designed to specifically target molecular alterations in individual patients. Several panel discussions were held to emphasize (ethical) issues associated with personalized medicine, including genetic cancer counseling.

Indexed as

Precision MedicineGenetic CounselingHumansNeoplasmsPortugalRare DiseasesTranscriptomeCancer geneticsGenome architectureHuman geneticsPersonalized medicineRare disorders

Identifiers

PMID29633150
PMCPMC12995218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.